• WindRose Health Investors closed its seventh fund, WindRose Health Investors VII, at $2.6 billion. • Fund VII reached its hard cap and is significantly larger than Fund VI, which closed at $1.4 billion. • The fund was raised in just six months, supported by both existing and new investors from the Americas, Europe, the Middle East and Asia. • Managing Partner Oliver T. Moses highlighted investor confidence and emphasized plans to invest in innovative, tech-enabled healthcare businesses. • Fund VII aims to make 11–13 total investments. • The fund expects to complete its first two acquisitions by year-end 2025. • Investors include pensions, insurance companies, financial institutions, foundations, funds-of-funds and family offices. • Catherine Coleman, Head of Investor Relations, noted strong investor confidence despite a challenging fundraising environment. • WindRose cites strong value creation capabilities aligned with the direction of the healthcare industry.
• Fund VII reached its hard cap and is significantly larger than Fund VI, which closed at $1.4 billion.
• The fund was raised in just six months, supported by both existing and new investors from the Americas, Europe, the Middle East and Asia.
• Managing Partner Oliver T. Moses highlighted investor confidence and emphasized plans to invest in innovative, tech-enabled healthcare businesses.
• Fund VII aims to make 11–13 total investments.
• The fund expects to complete its first two acquisitions by year-end 2025.
• Investors include pensions, insurance companies, financial institutions, foundations, funds-of-funds and family offices.
• Catherine Coleman, Head of Investor Relations, noted strong investor confidence despite a challenging fundraising environment.
• WindRose cites strong value creation capabilities aligned with the direction of the healthcare industry.